UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gestational age and sex interaction and risk for autism spectrum disorder in extremely preterm newborns: an 18‑month follow‑up study

European psychiatry, 2024-08, Vol.67 (S1), p.S281-S281

2024

Volltextzugriff (PDF)

Relationship between cognition and age at onset of first-episode psychosis: comparative study between adolescents, young adults, and adults

European child & adolescent psychiatry, 2023-04, Vol.32 (4), p.639-649

2023

Volltextzugriff (PDF)

Social Cognition in Autism and Schizophrenia Spectrum Disorders: The Same but Different?

Journal of autism and developmental disorders, 2020-08, Vol.50 (8), p.3046-3059

2020

Volltextzugriff (PDF)

The effects of second-generation antipsychotics on food intake, resting energy expenditure and physical activity

European journal of clinical nutrition, 2014-02, Vol.68 (2), p.146-152

2014

Volltextzugriff (PDF)

Insular pathology in young people with high-functioning autism and first-episode psychosis

Psychological medicine, 2017-10, Vol.47 (14), p.2472-2482

2017

Volltextzugriff (PDF)

The Positive and Negative Syndrome Scale for Schizophrenia Autism Severity Scale (PAUSS) in a sample of early-onset psychosis

European psychiatry, 2023-03, Vol.66 (S1), p.S443-S444

2023

Volltextzugriff (PDF)

P.7.a.005 Antipsychotic metabolic effects in bipolar youth: comparison with other psychotic and non-psychotic diagnoses

European neuropsychopharmacology, 2010, Vol.20, p.S613-S613

2010

Volltextzugriff (PDF)

S.01.03 Treatment of bipolar disorders in children and adolescents

European neuropsychopharmacology, 2009, Vol.19, p.S176-S176

2009

Volltextzugriff (PDF)

Biomarkers of oxidative stress and inflammation in urine samples of extremely preterm newborns and their association with risk for autism at age 6 months

European psychiatry, 2023-03, Vol.66 (S1), p.S585-S585

2023

Volltextzugriff (PDF)

Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study

European archives of psychiatry and clinical neuroscience, 2018-10, Vol.268 (7), p.699-711

2018

Volltextzugriff (PDF)

Negative symptoms predict functional outcome of early-onset psychosis

European psychiatry, 2007-03, Vol.22, p.S125-S125

2007

Volltextzugriff (PDF)

Liver-function tests in children and adolescents on antipsychotics: a one-year follow-up study

European neuropsychopharmacology, 2016-10, Vol.26, p.S734-S735

2016

Volltextzugriff (PDF)

UADO: A centre for the study of neuro-development within the CIBERSAM

The European journal of psychiatry, 2009-01, Vol.23 (supplement), p.9-16

2009

Volltextzugriff (PDF)

Are children treated with second-generation antipsychotics at higher risk of weight gain than adults?

European neuropsychopharmacology, 2016-10, Vol.26, p.S738-S739

2016

Volltextzugriff (PDF)

Short-term weight gain in antipsychotic-naïve pediatric and adult patients with psychosis treated with second-generation antipsychotics

European neuropsychopharmacology, 2016-10, Vol.26, p.S570-S570

2016

Volltextzugriff (PDF)

P.7.b.017 Premorbid to post-morbid functional adjustment course in adolescents after a first episode psychosis

European neuropsychopharmacology, 2014-10, Vol.24, p.S715-S716

2014

Volltextzugriff (PDF)

EPA-0863 - Progression of changes in brain structure and executive functions in children and adolescents with first-episode psychosis

European psychiatry, 2014, Vol.29, p.1-1

2014

Volltextzugriff (PDF)

Effects of functional remediation on neurocognitively impaired bipolar patients: enhancement of verbal memory

Psychological medicine, 2016-01, Vol.46 (2), p.291-301

2016

Volltextzugriff (PDF)

P.3.023 Metabolic risk after six months of treatment with second-generation antipsychotics in antipsyehotic-naïve children and adolescents

European neuropsychopharmacology, 2012-03, Vol.22, p.S71-S72

2012

Volltextzugriff (PDF)

P.1.e.036 White matter microstructure in Asperger syndrome patients compared with healthy controls

European neuropsychopharmacology, 2011, Vol.21, p.S324-S324

2011

Volltextzugriff (PDF)

P.1.e.038 Differences in corpus callosum composition between Asperger syndrome and healthy adolescents: a tractography study

European neuropsychopharmacology, 2011, Vol.21, p.S325-S326

2011

Volltextzugriff (PDF)

P.3.c.049 Risk of adverse health outcome and metabolic syndrome in adolescents treated with antipsychotics: preliminary results

European neuropsychopharmacology, 2011, Vol.21, p.S496-S497

2011

Volltextzugriff (PDF)

P.3.004 Risk for adverse health outcome in antipsychotic-naïve adolescents after 12 months of treatment with second-generation antipsychotics

European neuropsychopharmacology, 2011, Vol.21, p.S61-S62

2011

Volltextzugriff (PDF)

P.7.c.003 Obesogenic capacity of second-generation antipsychotics in naïve-adolescents and their impact on leptin, adiponectin and ghrelin

European neuropsychopharmacology, 2011, Vol.21, p.S605-S606

2011

Volltextzugriff (PDF)

P.7.a.012 Dyskinesia in naïve children and adolescents treated with olanzapine, risperidone and quetiapine: three months follow up

European neuropsychopharmacology, 2010, Vol.20, p.S617-S617

2010

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(47)

Sprache

Englisch
(46)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Gestational age and sex interaction and risk for autism spectrum disorder in extremely preterm newborns: an 18‑month follow‑up study

Relationship between cognition and age at onset of first-episode psychosis: comparative study between adolescents, young adults, and adults

Social Cognition in Autism and Schizophrenia Spectrum Disorders: The Same but Different?

The effects of second-generation antipsychotics on food intake, resting energy expenditure and physical activity

Insular pathology in young people with high-functioning autism and first-episode psychosis

The Positive and Negative Syndrome Scale for Schizophrenia Autism Severity Scale (PAUSS) in a sample of early-onset psychosis

P.7.a.005 Antipsychotic metabolic effects in bipolar youth: comparison with other psychotic and non-psychotic diagnoses

S.01.03 Treatment of bipolar disorders in children and adolescents

Biomarkers of oxidative stress and inflammation in urine samples of extremely preterm newborns and their association with risk for autism at age 6 months

Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study

Negative symptoms predict functional outcome of early-onset psychosis

Liver-function tests in children and adolescents on antipsychotics: a one-year follow-up study

UADO: A centre for the study of neuro-development within the CIBERSAM

Are children treated with second-generation antipsychotics at higher risk of weight gain than adults?

Short-term weight gain in antipsychotic-naïve pediatric and adult patients with psychosis treated with second-generation antipsychotics

P.7.b.017 Premorbid to post-morbid functional adjustment course in adolescents after a first episode psychosis

EPA-0863 - Progression of changes in brain structure and executive functions in children and adolescents with first-episode psychosis

Effects of functional remediation on neurocognitively impaired bipolar patients: enhancement of verbal memory

P.3.023 Metabolic risk after six months of treatment with second-generation antipsychotics in antipsyehotic-naïve children and adolescents

P.1.e.036 White matter microstructure in Asperger syndrome patients compared with healthy controls

P.1.e.038 Differences in corpus callosum composition between Asperger syndrome and healthy adolescents: a tractography study

P.3.c.049 Risk of adverse health outcome and metabolic syndrome in adolescents treated with antipsychotics: preliminary results

P.3.004 Risk for adverse health outcome in antipsychotic-naïve adolescents after 12 months of treatment with second-generation antipsychotics

P.7.c.003 Obesogenic capacity of second-generation antipsychotics in naïve-adolescents and their impact on leptin, adiponectin and ghrelin

P.7.a.012 Dyskinesia in naïve children and adolescents treated with olanzapine, risperidone and quetiapine: three months follow up

Suchergebnisse filtern